Literature DB >> 8460632

Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes.

H Vaziri1, F Schächter, I Uchida, L Wei, X Zhu, R Effros, D Cohen, C B Harley.   

Abstract

The telomere hypothesis of cellular aging proposes that loss of telomeric DNA (TTAGGG) from human chromosomes may ultimately cause cell-cycle exit during replicative senescence. Since lymphocytes have a limited replicative capacity and since blood cells were previously shown to lose telomeric DNA during aging in vivo, we wished to determine: (a) whether accelerated telomere loss is associated with the premature immunosenescence of lymphocytes in individuals with Down syndrome (DS) and (b) whether telomeric DNA is also lost during aging of lymphocytes in vitro. To investigate the effects of aging and trisomy 21 on telomere loss in vivo, genomic DNA was isolated from peripheral blood lymphocytes of 140 individuals (age 0-107 years), including 21 DS patients (age 0-45 years). Digestion with restriction enzymes HinfI and RsaI generated terminal restriction fragments (TRFs), which were detected by Southern analysis using a telomere-specific probe (32P-(C3TA2)3). The rate of telomere loss was calculated from the decrease in mean TRF length, as a function of donor age. DS patients showed a significantly higher rate of telomere loss with donor age (133 +/- 15 bp/year) compared with age-matched controls (41 +/- 7.7 bp/year) (P < .0005), suggesting that accelerated telomere loss is a biomarker of premature immunosenescence of DS patients and that it may play a role in this process. Telomere loss during aging in vitro was calculated for lymphocytes from four normal individuals, grown in culture for 10-30 population doublings. The rate of telomere loss was approximately 120 bp/cell doubling, comparable to that seen in other somatic cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460632      PMCID: PMC1682068     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  ANEUPLOIDY IN THE DEGENERATIVE PHASE OF SERIAL CULTIVATION OF HUMAN CELL STRAINS.

Authors:  E SAKSELA; P S MOORHEAD
Journal:  Proc Natl Acad Sci U S A       Date:  1963-08       Impact factor: 11.205

Review 2.  Genetic syndromes in man with potential relevance to the pathobiology of aging.

Authors:  G M Martin
Journal:  Birth Defects Orig Artic Ser       Date:  1978

3.  Purification of human T and B cells by a discontinuous density gradient of percoll.

Authors:  C Gutierrez; R R Bernabe; J Vega; M Kreisler
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

4.  Telomere end-replication problem and cell aging.

Authors:  M Z Levy; R C Allsopp; A B Futcher; C W Greider; C B Harley
Journal:  J Mol Biol       Date:  1992-06-20       Impact factor: 5.469

5.  Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos.

Authors:  P A Benn
Journal:  Am J Hum Genet       Date:  1976-09       Impact factor: 11.025

6.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

7.  [Principle of marginotomy in template synthesis of polynucleotides].

Authors:  A M Olovnikov
Journal:  Dokl Akad Nauk SSSR       Date:  1971

Review 8.  The molecular structure of centromeres and telomeres.

Authors:  E H Blackburn
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

9.  Isolation of large numbers of fully viable human neutrophils: a preparative technique using percoll density gradient centrifugation.

Authors:  D C Dooley; J F Simpson; H T Meryman
Journal:  Exp Hematol       Date:  1982-08       Impact factor: 3.084

10.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

Authors:  C M Counter; A A Avilion; C E LeFeuvre; N G Stewart; C W Greider; C B Harley; S Bacchetti
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  157 in total

Review 1.  Cellular and molecular mechanisms of aging and age related diseases.

Authors:  R Ladislas
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

Review 2.  Differences in the regulation of CD4 and CD8 T-cell clones during immune responses.

Authors:  P C Beverley; M K Maini
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

Review 3.  Telomeres: the time factor in essential hypertension.

Authors:  A Aviv; W Zahorodny
Journal:  Curr Hypertens Rep       Date:  2001-02       Impact factor: 5.369

4.  Functional requirement of p23 and Hsp90 in telomerase complexes.

Authors:  S E Holt; D L Aisner; J Baur; V M Tesmer; M Dy; M Ouellette; J B Trager; G B Morin; D O Toft; J W Shay; W E Wright; M A White
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

5.  Improved in situ detection method for telomeric tandem repeats in metaphase spreads and interphase nuclei.

Authors:  V Uhlmann; M Prasad; I Silva; K Luettich; L Grande; L Alonso; M Thisted; K J Pluzek; J Gorst; M Ring; M Sweeney; C Kenny; C Martin; J Russell; N Bermingham; M O'Donovan; O Sheils; J J O'Leary
Journal:  Mol Pathol       Date:  2000-02

Review 6.  Telomerase: biological function and potential role in cancer management.

Authors:  V D Chatziantoniou
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

7.  Telomere length regulation during postnatal development and ageing in Mus spretus.

Authors:  G M Coviello-McLaughlin; K R Prowse
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

Review 8.  How long should telomeres be?

Authors:  A Aviv; C B Harley
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 9.  The role of telomerase expression and telomere length maintenance in human and mouse.

Authors:  N P Weng; R J Hodes
Journal:  J Clin Immunol       Date:  2000-07       Impact factor: 8.317

10.  Impaired germinal center reaction in mice with short telomeres.

Authors:  E Herrera; C Martínez-A; M A Blasco
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.